Paper3910058
Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque.
Vlaicu R and 3 others. Atherosclerosis, 1985. Cited by 160 papers, by iCite.
Cite this record
ConductScience Library. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Papers, record 3910058. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3910058
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aorta | Major topic |
| Arteriosclerosis | Major topic |
| Complement System Proteins | Major topic |
| Adult | |
| Aged | |
| Complement Membrane Attack Complex | |
| Fluorescent Antibody Technique | |
| Humans | |
| Immunochemistry | |
| Immunoenzyme Techniques | |
| Immunoglobulins | |
| Middle Aged |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39635529 | The complement system in lipid-mediated pathologies. | Front Immunol | 2024 | https://conductscience.org/library/papers/39635529 | PubMed |
| 31938082 | Complement activation in the arteries of patients with severe atherosclerosis. | Int J Clin Exp Pathol | 2018 | https://conductscience.org/library/papers/31938082 | PubMed |
| 31193778 | Induction of decay accelerating factor and membrane cofactor protein by resveratrol attenuates complement deposition in human coronary artery endothelial cells. | Biochem Biophys Rep | 2019 | https://conductscience.org/library/papers/31193778 | PubMed |
| 28242049 | High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis. | Atherosclerosis | 2017 | https://conductscience.org/library/papers/28242049 | PubMed |
| 26754764 | The role of complement system in adipose tissue-related inflammation. | Immunol Res | 2016 | https://conductscience.org/library/papers/26754764 | PubMed |
| 26640806 | Mannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic Patients. | J Diabetes Res | 2016 | https://conductscience.org/library/papers/26640806 | PubMed |
| 26091721 | The role of complement activation in atherogenesis: the first 40 years. | Immunol Res | 2016 | https://conductscience.org/library/papers/26091721 | PubMed |
| 24818041 | Distinct functions of specialized dendritic cell subsets in atherosclerosis and the road ahead. | Scientifica (Cairo) | 2014 | https://conductscience.org/library/papers/24818041 | PubMed |
| 24278688 | Complement activation: an emerging player in the pathogenesis of cardiovascular disease. | Scientifica (Cairo) | 2012 | https://conductscience.org/library/papers/24278688 | PubMed |
| 22771788 | Humoral innate immune response and disease. | Clin Immunol | 2012 | https://conductscience.org/library/papers/22771788 | PubMed |
| 21816131 | CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21816131 | PubMed |
| 19959238 | The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice. | Mol Immunol | 2010 | https://conductscience.org/library/papers/19959238 | PubMed |
| 19025116 | Platelet mediated complement activation. | Adv Exp Med Biol | 2008 | https://conductscience.org/library/papers/19025116 | PubMed |
| 18432523 | Expression of complement components and inhibitors on platelet microparticles. | Platelets | 2008 | https://conductscience.org/library/papers/18432523 | PubMed |
| 16297155 | Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system. | Clin Exp Immunol | 2005 | https://conductscience.org/library/papers/16297155 | PubMed |
| 15258311 | The role of complement activation in atherosclerosis. | Immunol Res | 2004 | https://conductscience.org/library/papers/15258311 | PubMed |
| 12853376 | Lipoprotein autoantibodies: measurement and significance. | Clin Diagn Lab Immunol | 2003 | https://conductscience.org/library/papers/12853376 | PubMed |
| 11238052 | Generation of C-reactive protein and complement components in atherosclerotic plaques. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11238052 | PubMed |
| 9646095 | [Coronary heart disease as inflammatory disease of the vascular bed? Etiology, sequela or misconception?]. | Herz | 1998 | https://conductscience.org/library/papers/9646095 | PubMed |
| 8675620 | Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. | J Clin Invest | 1995 | https://conductscience.org/library/papers/8675620 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3910058
GET https://conductscience.org/api/papers/v1/3910058/cited_by?page=2